Ironwood Pharmaceuticals, Inc. - Class A Common Stock (NQ: IRWD )
1.920
-0.090
(-4.48%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Headline News about Ironwood Pharmaceuticals, Inc. - Class A Common Stock
![](https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp)
![](https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp)
![](https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp)
![](/next-assets/images/schema-image-default.png)
Earnings Preview: Ironwood Pharmaceuticals
November 06, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
A Preview Of Ironwood Pharmaceuticals's Earnings
February 14, 2024
Via Benzinga
![](https://talkmarkets.com/images/logos/talkmarkets.png)
Chart Of The Day: Ironwood Pharma - Gastrointestinal Products
February 13, 2024
Via Talk Markets
![](https://www.chartmill.com/images/uploads/CM_Aftermarket_Movers_Small_free_e077945a19.webp)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/06/21/movers-image_11.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/05/09/Wall-Street-US-stocks.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2018/01/biotechmsn.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/03/07/image45_0.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Thursday's Intraday Session
February 29, 2024
Via Benzinga
![](https://schaeffers-cdn.s3.amazonaws.com/images/default-source/schaeffers-cdn-images/2024/feb/mmc/mmc-feb29.png?sfvrsn=1398a606_2)
![](https://cdn.benzinga.com/files/images/story/2024/02/29/image28.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/Labs_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/02/29/image48.jpg?width=1200&height=800&fit=crop)
Nasdaq Gains 100 Points Following PCE Data
February 29, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://investorplace.com/wp-content/uploads/2022/06/psny1600.png)
![](https://www.investors.com/wp-content/uploads/2018/02/stock-pharmaceutical-5-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/Wall-Street-bull_1.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/10/medicine.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 29, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/02/15/image39.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
September 28, 2023
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.